Most patients with heterozygous SLC2A1 mutations exhibit GLUT1-deficiency syndrome characterized by low CSF-to-blood glucose ratios together with epilepsy, developmental delay, microcephaly, ataxia, and PxD [14]. The gene discussed is SLC2A1; the disease is cerebellar ataxia.